Trials / Conditions / Aspergillosis Invasive

Aspergillosis Invasive

9 registered clinical trials studyying Aspergillosis Invasive — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Liposomal Amphotericin B in Invasive Aspergillosis With Hepatic Dysfunction NCT07337720	Southeast University, China	N/A
Completed	Performance Evaluation of the Fujifilm Wako Beta-D-glucan Technique in the Diagnosis of Major Invasive Fungal NCT07272915	Central Hospital, Nancy, France	—
Not Yet Recruiting	Individualized First Maintenance Doses of Voriconazole Through a Multiparametric Algorithm NCT06582186	University Hospital, Grenoble	Phase 4
Recruiting	Study on Theraputic Drug Monitoring and Phamacokinetics of Isavuconazole in Children NCT06440915	Shanghai Children's Medical Center	N/A
Terminated	Isavuconazole for the Prevention of COVID-19-associated Pulmonary Aspergillosis NCT04707703	Jeffrey Jenks, MD, MPH	Phase 3
Completed	Invasive Pulmonary Aspergillosis Complicating Influenza Infection NCT03391492	Universitaire Ziekenhuizen KU Leuven	—
Completed	CYP2C19 Genotype-Specific Dosing Plus TDM on Reaching Therapeutic Voriconazole Blood Levels NCT03731169	University Health Network, Toronto	Phase 4
Terminated	Novel Biomarkers for Invasive Aspergillosis NCT03004092	Universitaire Ziekenhuizen KU Leuven	N/A
Withdrawn	A Study to Evaluate the Effectiveness of Voriconazole + Micafungin Versus Voriconazole Alone for Invasive Aspe NCT00423163	Astellas Pharma Inc	Phase 4